JBT MAREL Corp's acquisition of Marel hf. at the start of 2025 doubled its revenue, expanding its portfolio to cover protein processing through preparation and packaging technologies globally. While operating income rose significantly, net income swung negative due to integration expenses and increased financing costs. The company is navigating fixed-price contract risks, supply chain inflation, and regulatory compliance challenges while investing heavily in digital innovation and sustainability. Leveraging a multi-billion-dollar debt package including Term Loan B and convertible notes, JBT MAREL maintains liquidity to support ongoing integration and capital expenditures. Dividend payments increased but share buybacks ceased, reflecting capital allocation balance amid earnings pressure. Investors should monitor integration milestones, supply chain normalization, and margin recovery in 2026.